Summarized by Masters of Longevity from Longevity Technology.
A piece about a new diagnostic partnership pairing a quick digital cognitive screen with a blood-based molecular test to reshape early Alzheimer’s detection.
Key Takeaways
- A brief, self‑administered digital cognitive test can quickly triage primary‑care patients for further Alzheimer’s evaluation.
- A blood circRNA signature adds biological confirmation and can predict progression years before clinical Alzheimer’s symptoms.
- Combining functional digital assessment with a confirmatory blood test could expand scalable early detection and improve trial enrichment.
